9DO Stock Chart & Stats
€0.02
€0.00(0.00%)
At close: 4:00 PM EDT
€0.02
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.06
Previous CloseN/A
Volume0.00
Average Volume (3M)533.00
Market Cap
€5.40M
Enterprise Value€7.10
Total Cash (Recent Filing)€1.60M
Total Debt (Recent Filing)€34.51K
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding192,435,550
10 Day Avg. Volume0
30 Day Avg. Volume533
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ScalingRevenue has increased substantially across the reported periods, indicating improving commercial traction and a growing business base. If this expansion continues, greater scale could support operating leverage, strengthen market presence, and provide a broader foundation for future profitability.
Narrowing LossesThe sharp reduction in net losses shows that financial performance is improving as revenue scales and losses become more manageable. Continued progress toward break-even would reduce dependence on external funding, improve resilience, and make future earnings more sustainable.
Low Financial LeverageVery low debt relative to equity limits balance-sheet risk and reduces the burden of interest and refinancing obligations. This conservative capital structure gives Glow LifeTech more flexibility to fund operations, pursue growth, or withstand periods of weaker performance.
Bears Say
Negative Profit MarginsDespite revenue growth and narrower losses, the company remains unprofitable at both the operating and net levels. Negative margins indicate that current scale has not yet produced sufficient efficiency, leaving earnings sensitive to spending discipline and the pace of further growth.
Negative Cash GenerationGlow LifeTech is still consuming cash rather than funding operations internally, which limits financial self-sufficiency. Although the burn rate has improved from earlier years, ongoing negative operating and free cash flow may require continued cost control or outside capital.
Negative Return On EquityNegative return on equity shows that shareholder capital is not yet generating positive returns because losses remain ongoing. Until the company reaches sustainable profitability, capital efficiency will remain weak and the balance-sheet improvement will not translate into attractive operating returns.
Glow LifeTech News
9DO FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was <€0.01 and its highest was €0.06 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is €5.40M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Dec 01, 2026 which is in 77 days.
How were Glow LifeTech’s earnings last quarter?
Glow LifeTech released its earnings results on Aug 25, 2026. The company reported >-€0.001 earnings per share for the quarter.
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,435,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Glow LifeTech reported an EPS of >-€0.001 in its last earnings report. Following the earnings report the stock price went up 61.111%.
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in DE:9DO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―